Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Goldman

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Circulation|June 10, 2009
DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative studySteven Goldman, Madeline McCarren, Eugene Morkin, et al.
The New England Journal of Medicine|December 31, 2004
Coronary-artery revascularization before elective major vascular surgeryEdward O McFalls, Herbert B Ward, Thomas E Moritz, et al.
Plos One|February 4, 2026
Yucatan Miniswine Model of Atrial Fibrillation: Clinical RelevancePouria Mostafizi, Eli Lefkowitz, Jacob Ref, et al.
The New England Journal of Medicine|December 19, 2008
Glucose control and vascular complications in veterans with type 2 diabetesWilliam Duckworth, Carlos Abraira, Thomas Moritz, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 24, 2017
Randomized comparison of the clinical outcome of single versus multiple arterial grafts: the ROMA trial-rationale and study protocolMario Gaudino, John H Alexander, Faisal G Bakaeen, et al.
Circulation|August 30, 2021
Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment StrategiesIosif Xenogiannis, Marco Zenati, Deepak L Bhatt, et al.
Diabetes|August 5, 2009
Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosisPeter D Reaven, Thomas E Moritz, Dawn C Schwenke, et al.
Clinical Cardiology|August 26, 2017
Rationale and design of the Drug-Eluting Stents vs Bare-Metal Stents in Saphenous Vein Graft Angioplasty (DIVA) TrialEmmanouil S Brilakis, Subhash Banerjee, Robert Edson, et al.
Circulation. Cardiovascular Interventions|February 6, 2020
Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA TrialFaisal Latif, Lauren Uyeda, Robert Edson, et al.
Lancet (London, England)|May 16, 2018
Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trialEmmanouil S Brilakis, Robert Edson, Deepak L Bhatt, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Circulation|June 10, 2009
DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative studySteven Goldman, Madeline McCarren, Eugene Morkin, et al.
The New England Journal of Medicine|December 31, 2004
Coronary-artery revascularization before elective major vascular surgeryEdward O McFalls, Herbert B Ward, Thomas E Moritz, et al.
Plos One|February 4, 2026
Yucatan Miniswine Model of Atrial Fibrillation: Clinical RelevancePouria Mostafizi, Eli Lefkowitz, Jacob Ref, et al.
The New England Journal of Medicine|December 19, 2008
Glucose control and vascular complications in veterans with type 2 diabetesWilliam Duckworth, Carlos Abraira, Thomas Moritz, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 24, 2017
Randomized comparison of the clinical outcome of single versus multiple arterial grafts: the ROMA trial-rationale and study protocolMario Gaudino, John H Alexander, Faisal G Bakaeen, et al.
Circulation|August 30, 2021
Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment StrategiesIosif Xenogiannis, Marco Zenati, Deepak L Bhatt, et al.
Diabetes|August 5, 2009
Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosisPeter D Reaven, Thomas E Moritz, Dawn C Schwenke, et al.
Clinical Cardiology|August 26, 2017
Rationale and design of the Drug-Eluting Stents vs Bare-Metal Stents in Saphenous Vein Graft Angioplasty (DIVA) TrialEmmanouil S Brilakis, Subhash Banerjee, Robert Edson, et al.
Circulation. Cardiovascular Interventions|February 6, 2020
Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA TrialFaisal Latif, Lauren Uyeda, Robert Edson, et al.
Lancet (London, England)|May 16, 2018
Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trialEmmanouil S Brilakis, Robert Edson, Deepak L Bhatt, et al.
Pageof 10